Kalli C. Catcott
Impact in
-
- interferon and immune responses
- Immune Response and Inflammation
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- interferon and immune responses 5
- Oncology 5
- HER2/EGFR in Cancer Research 2
- Co-authors
- Raghida A. Bukhalid (7 shared papers)Dorin Toader (8 shared papers)Timothy B. Lowinger (9 shared papers)Marc Damelin (9 shared papers)Jeremy R. Duvall (7 shared papers)Zhaohui Sunny Zhou (3 shared papers)Travis Monnell (5 shared papers)Chen‐Ni Chin (2 shared papers)
- Journals
- Cancer Research (3 papers)Nature Communications (1 paper)Journal of Medicinal Chemistry (1 paper)mAbs (1 paper)ChemBioChem (1 paper)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Kalli C. Catcott
12 papers receiving 135 citations
Peers
Comparison fields: 5 of 36
- Immunology 64
- Oncology 46
- Radiology, Nuclear Medicine and Imaging 32
- Infectious Diseases 23
- Molecular Biology 49
Countries citing papers authored by Kalli C. Catcott
This map shows the geographic impact of Kalli C. Catcott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalli C. Catcott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalli C. Catcott more than expected).
Fields of papers citing papers by Kalli C. Catcott
This network shows the impact of papers produced by Kalli C. Catcott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalli C. Catcott. The network helps show where Kalli C. Catcott may publish in the future.
Co-authors
The 25 scholars most cited alongside Kalli C. Catcott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 46 | |
| 2 | 2023 | 36 | |
| 3 | 2016 | 17 | |
| 4 | 2016 | 14 | |
| 5 | 2017 | 10 | |
| 6 | 2022 | 6 | |
| 7 | 2014 | 3 | |
| 8 | 2020 | 3 | |
| 9 | 2021 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2024 | 1 | |
| 12 | 2021 | 1 | |
| 13 | 2024 | 0 |
About Kalli C. Catcott
Kalli C. Catcott is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 13 papers that have together received 142 indexed citations. Recurring topics across this work include interferon and immune responses (5 papers), Cancer Research and Treatments (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Virus-based gene therapy research (3 papers), Epigenetics and DNA Methylation (2 papers), Neuroblastoma Research and Treatments (2 papers), RNA modifications and cancer (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Immunology (64 citations), Oncology (46 citations), Radiology, Nuclear Medicine and Imaging (32 citations), Infectious Diseases (23 citations) and Molecular Biology (49 citations). Kalli C. Catcott has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Raghida A. Bukhalid, Dorin Toader, Timothy B. Lowinger, Marc Damelin, Jeremy R. Duvall, Zhaohui Sunny Zhou, Travis Monnell, Chen‐Ni Chin, Melissa Dolan and K. W. Bentley. Their work appears in journals such as Cancer Research, Nature Communications, Journal of Medicinal Chemistry, mAbs and ChemBioChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.